Sfoglia per Rivista  HAEMATOLOGICA

Opzioni
Vai a: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Mostrati risultati da 68 a 87 di 142
Titolo Data di pubblicazione Autore(i) File
IL-7 is induced by IL-6 in human myeloma cells: role in multiple myeloma 1-gen-2003 Giuliani, Nicola; Colla, S.; Roti, Giovanni; Bonomini, S.; Hojden, M.; Sammarelli, Gabriella; Morandi, F. BATAILLE R.; Rizzoli, Vittorio
IL21R expressing CD14+CD16+ monocytes expand in multiple myeloma patients leading to increased osteoclasts 1-gen-2017 Bolzoni, Marina; Ronchetti, Domenica; Storti, Paola; Donofrio, Gaetano; Marchica, Valentina; Costa, Federica; Agnelli, Luca; Toscani, Denise; Vescovini, Rosanna; Todoerti, Katia; Bonomini, Sabrina; Sammarelli, Gabriella; Vecchi, Andrea; Guasco, Daniela; Accardi, Fabrizio; Palma, Benedetta Dalla; Gamberi, Barbara; Ferrari, Carlo; Neri, Antonino; Aversa, Franco; Giuliani, Nicola
ILF2-YB1 INTERACTION MODULATES RNA SPLICING TO INDUCE RESISTANCE TO DNA-DAMAGING AGENTS IN 1Q21-AMPLIFIED MULTIPLE MYELOMA 1-gen-2017 Marchesini, Matteo; Ogoti, Y; Fiorini, E; D'Anca, M; Storti, Paola; Nezi, L; Samur, Mk; Ganan gomez, I; Fulciniti, Mt; Zhang, L; Giuliani, Nicola; Bohannan, Z; Clise dwyer, K; Munshi, N; Orlowsky, R; Garcia manero, G; Depinho, Ra; Colla, Simona
The IMID CC-4047 (Pomalidomide) inhibits myeloma-induced osteoclast formation 1-gen-2010 Abeltino, Manuela; Bolzoni, Marina; Storti, Paola; Bonomini, S; Pariyyarath, R; Rizzoli, Vittorio; Giuliani, Nicola
IMPACT OF COMORBIDITIES AND BODY MASS INDEX ON SURVIVAL IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB 1-gen-2017 Palandri, F; Tiribelli, M; Bonifacio, M; Palumbo, Ga; Tieghi, A; Polverelli, N; Bergamaschi, M; Cavazzini, F; Isidori, A; Binotto, G; Cimino, G; D'Adda, M; Crugnola, M; Bosi, C; Sgherza, N; Spinsanti, M; Molica, M; Fama, A; Andriani, A; Cerqui, E; Lazzaro, A; Scaffidi, L; Massaro, F; Latagliata, R; Fanin, R; Russo, D; Aversa, Franco; Cuneo, A; Cavo, M; Vianelli, N; Breccia, M.
IMPACT OF TREATMENT WITH IDELALISIB PLUS RITUXIMAB ON CLINICAL AND CYTOGENETICS PROFILE IN RELAPSE/REFRACTORY CLL: THE EXPERIENCE OF THE UNIVERSITY HOSPITAL OF PARMA 1-gen-2018 Pagliaro, L; Sammarelli, G; Russo, F; Plenteda, C; Todaro, G; Pelagatti, L; Notarfranchi, L; Falcioni, F; Aversa, F; Re, F
Impact of XIAP protein levels on the survival of myeloma cells 1-gen-2009 Desplanques, G; Giuliani, Nicola; Delsignore, R; Rizzoli, Vittorio; Bataille, R; BARILLÉ NION, S.
Importance of gallium scan restaging for curative treatment of mediastinal lymphomas 1-gen-2001 Zinzani, Pl; Monetti, N; Zompatori, Maurizio; Stefoni, V; Fanti, S; Baccarani, M; Tura, S.
IN VITRO CHARACTERISTICS OF HEMATOPOIETIC PROGENITORS FROM PRIMARY MYELOFIBROSIS PATIENTS CORRELATE WITH IPSS/DIPSS RISK CATEGORY 1-gen-2015 Masselli, Elena; Carubbi, Cecilia; Gobbi, Giuliana; Mirandola, Prisco; Galli, Daniela; Martini, Silvia; Pozzi, Giulia; Gildone, Maria; Albanese, Cristina; Bonomini, Sabrina; Crugnola, Monica; Craviotto, Luisa; Aversa, Franco; Vitale, Marco
INCIDENCE AND RISK FACTORS OF CARDIOVASCULAR ADVERSE EVENTS IN A LARGE POPULATION OF NEWLY-DIAGNOSED, TRANSPLANT INELIGIBLE MYELOMA PATIENTS TREATED WITH CARFILZOMIB 1-gen-2017 Bringhen, S; Mina, R; Petrucci, Mt; Giuliani, Nicola; Angelucci, E; Genuardi, M; Di Toritto, Tc; Malfitano, A; Musto, P; Ria, R; Ciccone, G; Saraci, E; Offidani, M; Musolino, C; Troia, R; Liberati, Am; De Paoli, L; Ballanti, S; Esma, F; Galieni, P; Cavo, M; Conticello, C; Zambello, R; Corradini, P; Benevolo, G; Palumbo, A; Sonneveld, P; Boccadoro, M.
Interleukin-3 induces activin A in bone marrow monocytes: role in multiple myeloma patients 1-gen-2012 Guasco, D; Bolzoni, Marina; Silbermann, R; Storti, Paola; Toscani, Denise; Bonomini, S; Dallapalma, B; Roodman, Gd; Aversa, Franco; Giuliani, Nicola
Intracranial hematopoiesis in a patient with AIDS-related central nervous system lymphoma and severe pancytopenia. 1-gen-2007 Musolino, A; Guazzi, A; Lazzaretti, Mirca; Pezzuolo, D; Calzetti, C; DEGLI ANTONI, A; Ardizzoni, A.
Intravenous neridronate for treatment of skeletal involvment in patients with multiple myeloma undergoing autologous stem cell transplantation 1-gen-2005 Pittari, G; Costi, D; Mangoni, L; Caramatti, C; Baroni, Maria Cristina; Rizzoli, Vittorio
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study. 1-gen-2010 Pagano, L; Caira, M; Candoni, A; Offidani, M; Martino, B; Specchia, G; Pastore, D; Stanzani, M; Cattaneo, C; Fanci, R; Caramatti, Cecilia; Rossini, F; Luppi, M; Potenza, L; Ferrara, F; Mitra, Me; Fadda, Rm; Invernizzi, R; Aloisi, T; Picardi, M; Bonini, A; Vacca, A; Chierichini, A; Melillo, L; de Waure, C; Fianchi, L; Riva, M; Leone, G; Aversa, Franco; Nosari, A.
Lack of receptor activator of nuclear factor-kB ligand (RANKL) expression andfunctional production by human multiple myeloma cells 1-gen-2005 Giuliani, Nicola; Colla, S; Morandi, F; BARILLE NION, S; Rizzoli, Vittorio
LENALIDOMIDE INCREASES HUMAN DENDRITIC CELL MATURATION MODULATING BOTH MONOCYTE DIFFERENTIATION AND MESENCHYMAL STROMAL CELL INHIBITORY PROPERTIES 1-gen-2015 Costa, Federica; Bolzoni, Marina; Vescovini, Rosanna; Toscani, Denise; Accardi, Fabrizio; Storti, Paola; Marchica, Valentina; Guasco, Daniela; Dalla Palma, Benedetta; Aversa, Franco; Giuliani, Nicola
Lenalidomide plus Dexamethasone (RD) vs Melphalan-Lenalidomide-Prednisone (MPR) or Cyclophosphamide-Prednisone-Lenalidomide (CPR) in elderly community-based newly diagnosed multiple myeloma patients: efficacy and safety results from a Phase 3 trial 1-gen-2013 Magarotto V, Bringhen S; Offidani, M; Am, Liberati; Benevolo, G; Patriarca, F; Cavalli, M; Rossi, D; Aitoro, Gn; Omedè, P; Giuliani, Nicola; Galli, M; Mansueto, G; Palladino, C; Vittorio, M; Allegra, A; Falcone, A; Gay, F; Zambello, R; Ledda, A; Maratti, L; Musto, P; Hajek, R; Boccadoro, M.
Marriage and parenthood among childhood cancer survivors: A report from the italian AIEOP Off-Therapy Registry 1-gen-2011 Pivetta, Emanuele; Maule, Milena M.; Pisani, Paola; Zugna, Daniela; Haupt, Riccardo; Jankovic, Momcilo; Aricò, Maurizio; Casale, Fiorina; Clerico, Anna; di Montezemolo, Luca Cordero; Kiren, Valentina; Locatelli, Franco; Palumbo, Giovanna; Pession, Andrea; Pillon, Marta; Santoro, Nicola; Terenziani, Monica; Valsecchi, Maria Grazia; Dama, Elisa; Magnani, Corrado; Merletti, Franco; Pastore, Guido; Aversa, Franco
MDM2 inhibition synergistically enhances cytotoxicity of MEK1 inhibitor and Arsenic Trioxide (ATO) in AML blasts that retain a functional p53 pathway 1-gen-2008 Mazzera, L; Lunghi, P; Mangoni, Marcellina; Caramatti, C; Rizzoli, V; Bonati, Antonio
MEK-INHIBITORS/ARSENIC TRIOXIDE COMBINATION THERAPY AS A NOVEL TREATMENT OPTION FOR TYROSINE KINASE INHIBITORS-RESISTANT PH+-LEUKEMIA 1-gen-2020 Mazzera, L.; Abeltino, M.; Lombardi, G.; Cantoni, A. M.; Jottini, S.; Corradi, A.; Ricca, M.; Arienti, D.; Peli, A.; Perris, R.; Bonati, A.; Lunghi, P.
Mostrati risultati da 68 a 87 di 142
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile